A case of vaccine-associated paralytic poliomyelitis

Journal of Paediatrics and Child Health

Volumn 36, Issue 4, 2000, Pages 408-411

  Edwards, E A ^a,c   Grant, C C ^a   Huang, Q S ^d   Powell, K F H ^b   Croxson, M C ^b  

^a STARSHIP CHILDREN S HOSPITAL   (New Zealand)

^b AUCKLAND DISTRICT HEALTH BOARD   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d NONE

Author keywords

Infant; Provocation paralysis; Recipient; Vaccine associated poliomyelitis

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE;

ARTICLE; BACTERIAL INFECTION; CASE REPORT; CHILDHOOD DISEASE; DRUG INDUCED DISEASE; HUMAN; IMMUNIZATION; INFANT; MALE; PARALYSIS; POLIOMYELITIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VACCINATION; VIRUS DETECTION; VIRUS INFECTION; VIRUS VIRULENCE;

ELECTROMYOGRAPHY; HUMANS; INFANT; LEG; MALE; MUSCLE HYPOTONIA; PARALYSIS; POLIOMYELITIS; POLIOVIRUS VACCINE, ORAL;

EID: 0033867884     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1754.2000.00514.x     Document Type: Article

References (25)

1. Prevots DR, Sutter RW, Strebel PM, Weibel RE, Cochi SL. Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991: Implications for estimating the risk of vaccine-associated disease. Arch. Pediatr. Adolesc. Med. 1994; 148: 479-85.
2. Nkowane, BM, Wassilak SGF, Orenstein WA et al. Vaccine-associated paralytic poliomyelitis, United States: 1961-72. JAMA 1987; 257: 1335-40.
3. Bodian D. Viremia in experimental poliomyelitis. II. Viremia and the mechanism of the provoking effect of injections or trauma. Am. J. Hyg. 1954; 60: 358-70.
4. Sutter RW, Patriarca PA, Suleiman AJM. Attributable risk of DTP (diphtheria and tetanus toxoids and pertussis vaccine) injection in provoking paralytic poliomyelitis during a large outbreak in Oman. J. Infect. Dis. 1992; 165: 444-9.
5. Hill AB, Knowledon J. Inoculation and poliomyelitis; astatistical investigation in England and Wales 1949. BMJ 1950; 2: 1-6.
6. Strebel PM, Ion-Nedelcu N, Baughman AL, Sutter RW, Cochi SL. Intramuscular injections within 30 days of immunisation with oral poliovirus vaccine: A risk factor for vaccine-associated paralytic poliomyelitis. N. Engl. J. Med. 1995; 332: 500-6.
7. Sutter RW, Brink EW, Cochi SL et al. A new epidemiologic and laboratory classification system for paralytic poliomyelitis cases. Am. J. Public Health 1989; 79: 495-8.
8. Melnick JL. Polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In Fields BN, Knipe DM, Howley PM, eds. Fields Virology, 3rd edn. Lippincott-Raven, New York. 1996; 678-679.
9. Nicholson F, Meeloo G, Aiyar S, Banatvala JE, Muir P. Detection of enterovirus RNA in clinical samples by nested polymerase chain reaction for rapid diagnosis of enterovirus infection. J. Virol. Methods 1994; 48: 155-66.
10. Rantala H, Uhari M, Tuokko H, Stenvik M, Kinnunen L. Poliovaccine virus in the cerebrospinal fluid after oral polio vaccination. J. Infect. 1989; 19: 173-6.
11. Horsfall FL, Tamm L, eds. Viral and Rickettsial Infections in Man. 4th edn. Lippincott, Philadelphia, 1965.
12. Melnick JL. Live attenuated poliovirus vaccines. In: Plotkin SA, Mortimer EA, eds. Vaccines. 2nd edn. W.B. Saunders Company, Philadelphia, 1994: 155-204.
13. Georgescu MM, Balanant J, Ozden S, Crainic R. Random selection: A model for poliovirus infection of the central nervous system. J. Gen. Virol. 1997; 78: 1819-28.
14. Georgescu MM, Delpeyroux F, Tardy-Panit M et al. High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis. J. Virol. 1994; 68: 8089-101.
15. Bodian D. Poliomyelitis: Pathogenesis and histopathology. In: Horsfall, FL, Tamm, L, eds. Viral and Rickettsial Infections in Man 4th edn. Philadelphia, Lippincott, 1965; 430-438.
16. Hurst EW. The newer knowledge of virus disease of the nervous system: A review and an interpretation. Brain 1936; 59: 1-34.
17. Ren R, Racaniello VR. Poliovirus spreads from muscle to the central nervous system by neural pathways. J. Infect. Dis. 1992; 166: 747-52.
18. Dalakas MC, Illa I, Leon-Monzon M. Intramuscular injections and vaccine-associated poliomyelitis. N. Engl. J. Med. 1995; 333: 62.
19. Wright PF, Karzon DT. Minimising the risks associated with the prevention of poliomyelitis. N Engl. J. Med. 1995; 332: 529-30.
20. Izurieta HS, Sutter RW, Baughman AL, Strebel PM, Stevenson JM, Wharton M. Vaccine-associated paralytic poliomyelitis in the United States: No evidence of elevated risk after simultaneous intramuscular injections of vaccine. Pediatr. Infect. Dis. J. 1995; 14: 840-6.
21. Heffernan H, Edwards E, Grant C, Huang S. A case of vaccine-associated paralytic poliomyelitis. NZ Public Health Report 1999; 6: 33-5.
22. Centers for Disease Control and Prevention. Poliomyelitis prevention in the United States: Introduction of a sequential vaccination schedule of inactivated poliovirus followed by oral poliovirus. Recommendations of the Advisory Committee in Immunization Practices (ACIP). MMWR 1997; 46: 1-25.
23. Baker C, Eberhart-Phillips J. Polio vaccine: Should New Zealand make the change? NZ Med. J. 1997; 110: 340-2.
24. Durham G. Changing to injectable polio vaccine (Letter). NZ Med. J. 1997; 110: 402.
25. Mansoor O, Reid S. The future of the immunisation schedule: Recommendations of a workshop. NZ Med. J. 1999; 112: 52-5.